A CPMP Opinion for terfenadine containing medicinal products, pursuant to Article 12 of Council Directive 75/ 319/ EEC as amended, was adopted on 19 November 1997, recommending by a majority of 21 out of 24 votes, the maintenance of the Marketing Authorisations in accordance with the draft Summary of Product Characteristics set out in Annex I to that opinion.